🇺🇸 FDA
Patent

US 6372217

Methods for the treatment of CD7+ viral infection with TXU-7-PAP

expired A61KA61K47/6825A61K47/6849

Quick answer

US patent 6372217 (Methods for the treatment of CD7+ viral infection with TXU-7-PAP) held by Regents of the University of Minnesota expires Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Apr 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K47/6825, A61K47/6849, A61P, A61P31/12